ࡱ >
\ p None B a = c @ = Z ?N*8 X" 1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial1 Arial General ` Table_1 Control (20) Tac (20) p-value8 At screening visits during 3 months before randomization Hypertension (%) 7 (35.0) 9 (45.0) 0.748 Diabetets Mellitus (%) 0 (0.0) 1 (5.0) 1.000 DBP (mmHg)* 735 0.775 SBP (mmHg)* 1196 1187 0.603 Creatinine (mg/dL) 0.980.24 1.050.29 0.452 GFR (ml/min/1.73 m2) 83.322.4 80.121.5 0.645 UACR (mg/g cr)* 910561 975450 0.692 UPCR (mg/g cr)* 1193664 1291535 0.609 At enrollment visit Age (years) 40.112.8 36.911.4 0.403
Sex (Male, %) 6 (20.0) RAS blocker (%)* 11 (55.0) 0.527 Duration of illness (months)* 49.459.8 41.257.1 0.661 BMI (kg/m2) 23.34.5 22.53.8 0.574
DBP (mmHg) 746 733
SBP (mmHg) 1207 1178
Protein (g/L) 7.10.4 7.10.5 0.621
Albumin (g/L) 4.10.3 0.860 Cholesterol (mg/dL) 18430 19038 0.576 LDL-Cholesterol (mg/dL) 11027 10333 0.513 Hemoglobin (g/dL) 13.41.5 13.51.8 0.743 C-reactive protein (mg/dL) 0.0980.145 0.0440.062 0.134 0.980.26 1.060.30 0.379 GFR (ml/min/1.73 m2)* 84.623.2 79.621.6 0.482 4 5 5 9 ( % ) 4 (20.0) 6 0 8 9 ( % ) 6 (30.0) 8 (40.0) e"9 0 ( % ) 10 (50.0) 965459 1098635 1202500 1398809 0.362 3 0 0 9 9 9 ( % )
1 0 0 0 1 9 9 9 ( % )
2 0 0 0 2 9 9 9 ( % ) 3 (15.0)~ Hematuria* 15 (75.0) 13 (65.0) 0.490 Pathologic findings by Oxford classification* M score (1, %) 11 (64.7) 5 (31.3) 0.055 S score (1, %) 12 (70.6) 14 (87.5) 0.235 E score (1, %) 2 (11.8) 6 (37.5) 0.118 T score 0.607 0 14 (82.4) 11 (68.8) 1 4 (25.0) 2 1 (5.9) 1 (6.3)
d MbP?_ % ( * + &P &F